Femme et Homme
- | Pays :
- Italy
- Sweden
- Norway
- Les 8 autres...
- | Organes : -
- | Spécialités : -
Extrait
This study was a multicentre, double-blind, randomised, placebo-controlled parallel group study consisting of 4 visits over a period of 6 months. The primary variable was to assess theefficacy of esomeprazole 40 mg orally qd (E40) or esomeprazole 20 mg orally qd (E20) versus placebo orally qd after 6 months of treatment for the prevention of relapse of upper GI symptoms associated with NSAID use, including COX-2 selective NSAIDs, in patients receiving daily NSAID therapy.
Critère d'inclusion
- NSAIDs ,Upper-GI Symptoms